1. Product Monograph;Sigma Pharmaceuticals Pty Ltd,2003
2. Classification of abnormal involuntary movements in psychiatric patients;Gerlach;Neuropsychiatr Clin,1983
3. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine;Schillevoort;Ann Pharmacother,2001
4. Neuroleptic malignant syndrome with intravenous haloperidol;Levitt;Can J Psychiatry,1990
5. Haloperidol: neuroleptic malignant syndrome;Town;NZ Med J,1982